Are men the problem with male contraception?
Science could now offer contraceptive gels and pills for men, but questions remain over trials, and men's responsibility

A new gel that men rub into their shoulders every day is the latest in a series of developments that are not only changing the landscape of male contraceptive options, but also highlighting the challenges in winning men over to birth control.
The NES/T gel lowers sperm production, and in eight weeks it becomes as effective at preventing pregnancy as the female contraceptive pill. It follows the development of a male contraceptive pill which entered UK trials in December last year. The pill trials will determine whether the medication is "safe and effective", wrote author Jill Filipovic in The Guardian. "But the manufacturers are no doubt wondering about something else: will men take it?"
'Up for it'
Male contraceptive methods beyond condoms have evolved at a snail's pace compared to women's options, so why has it "taken so long?" wondered USA Today, to "get from sheep intestines to pills and hormonal gels?"
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Plenty of men are in favour of male hormonal contraception, as demonstrated by a 2023 YouGov poll suggesting that just over half of British men aged 18 to 44 would be open to taking a contraceptive pill. "Men and boys are afraid of accidental pregnancies", too, said one man speaking to The Times. "Count me in."
"I don't think I'm alone in suspecting that if they were genuinely up for it", a male pill "would have been invented long ago", said Anna Tyzack in The Telegraph. Tellingly, "when I asked fathers at my children's school if they'd take it, they all said they would, so long as it was safe and had no negative side effects".
'Resigned to female pain'
If men are likely to be put off by contraception's side effects, they're not alone. "Nearly half of all women who start taking the pill discontinue in the first year because of the side effects," said Tyzack.
The difference, said Charlie Gowans-Eglinton in The Times, is that "on the whole we're just more resigned, as a society, to female pain". While women still battle to get the medical establishment to take their experiences seriously, "trials of male hormonal pills have been cancelled" when those same side effects, such as acne and mood swings, "were deemed too severe". Despite the sometimes serious physical and emotional impact of hormonal birth control, women "take the risks, because our stakes are higher".
A big 'if'
"Ever since the invention of contraception – and before the concept even existed", said Helen Coffey in The Independent, "women have always known it's up to us to take care of the distinctly unsexy 'not falling pregnant' part of sex". Dr Diana Blithe, a clinical researcher in contraceptive health, told The Telegraph that "male contraception will always be a female issue".
There's also "the issue of trust", said Dazed. "How can women trust men who say they're on the pill, when stealthing – non-consensual condom removal – is so widespread?". Of course, "the vast majority of guys" aren't engaging in such "despicable" behaviour, said Coffey, but the very fact this crime is "prevalent enough to have developed its own moniker" is "enough reason to keep women convinced that birth control remains solely our domain".
And even with the best intentions, relying on men for birth control, "when the weight of a lapse of memory will fall on women's bodies, health, and careers if they don't – well, that's a big if", wrote Gowans-Eglinton in The Times.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
Chas Newkey-Burden has been part of The Week Digital team for more than a decade and a journalist for 25 years, starting out on the irreverent football weekly 90 Minutes, before moving to lifestyle magazines Loaded and Attitude. He was a columnist for The Big Issue and landed a world exclusive with David Beckham that became the weekly magazine’s bestselling issue. He now writes regularly for The Guardian, The Telegraph, The Independent, Metro, FourFourTwo and the i new site. He is also the author of a number of non-fiction books.
-
Who is actually running DOGE?
TODAY'S BIG QUESTION The White House said in a court filing that Elon Musk isn't the official head of Donald Trump's Department of Government Efficiency task force, raising questions about just who is overseeing DOGE's federal blitzkrieg
By Rafi Schwartz, The Week US Published
-
How does the Kennedy Center work?
The Explainer The D.C. institution has become a cultural touchstone. Why did Trump take over?
By Joel Mathis, The Week US Published
-
What are reciprocal tariffs?
The Explainer And will they fix America's trade deficit?
By Joel Mathis, The Week US Published
-
Oysters could help combat antibiotic resistance
Under the radar The mollusk shows infection-fighting abilities
By Devika Rao, The Week US Published
-
IVM is a better treatment than IVF for some women
The Explainer A less painful, less costly option for treating infertility emerges
By Theara Coleman, The Week US Published
-
What are the long-term effects of alcohol?
It's not just cancer
By Joel Mathis, The Week US Published
-
Marty Makary: the medical contrarian who will lead the FDA
In the Spotlight What Johns Hopkins surgeon and commentator Marty Makary will bring to the FDA
By David Faris Published
-
Will the murder of a health insurance CEO cause an industry reckoning?
Today's Big Question UnitedHealthcare CEO Brian Thompson was shot and killed in what police believe was a targeted attack
By Justin Klawans, The Week US Published
-
The growing list of conditions weight-loss drugs could help with
The Explainer Ozempic and similar drugs have been linked to possibly helping diseases beyond diabetes and obesity. Are they miracle drugs?
By Theara Coleman, The Week US Published
-
The great departure: Texas OB-GYNs are leaving the Lone Star State
Under the radar The state is suffering an exodus of health care professionals, creating more maternity care deserts
By Theara Coleman, The Week US Published
-
UK gynaecological care crisis: why thousands of women are left in pain
The Explainer Waiting times have tripled over the past decade thanks to lack of prioritisation or funding for women's health
By Harriet Marsden, The Week UK Published